AAAAAA
Results: 1-25/26
Authors:
Campbell, IW
Charbonnel, B
Citation: Iw. Campbell et B. Charbonnel, New advances in the management of insulin resistance in Type 2 diabetes - Chairmen's introduction, INT J CL PR, 2001, pp. 3-3
Authors:
Charbonnel, B
Sauvanet, JP
Citation: B. Charbonnel et Jp. Sauvanet, Current and perspectives of insulin treatment in type 2 diabetic patients, DIABETE MET, 27(5), 2001, pp. S15-S22
Authors:
Charbonnel, B
Balarac, N
Cazeneuve, B
Augendre-Ferrante, B
Le Thai, F
Drouin, P
Citation: B. Charbonnel et al., Which are the insulin treatment regimens used in France? The "Schema survey", DIABETE MET, 27(5), 2001, pp. 591-597
Authors:
Mauvais-Jarvis, F
Andreelli, F
Hanaire-Broutin, H
Charbonnel, B
Girard, J
Citation: F. Mauvais-jarvis et al., Therapeutic perspectives for type 2 diabetes mellitus: Molecular and clinical insights, DIABETE MET, 27(4), 2001, pp. 415-423
Authors:
Frenais, R
Maugeais, C
Ouguerram, K
Zair, Y
Bard, JM
Charbonnel, B
Magot, T
Krempf, M
Citation: R. Frenais et al., Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia, METABOLISM, 50(6), 2001, pp. 635-639
Authors:
Frenais, R
Nazih, H
Ouguerram, K
Maugeais, C
Zair, Y
Bard, JM
Charbonnel, B
Magot, T
Krempf, M
Citation: R. Frenais et al., In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus, J CLIN END, 86(5), 2001, pp. 1962-1967
Authors:
Maugeais, C
Ouguerram, K
Frenais, R
Maugere, P
Charbonnel, B
Magot, T
Krempf, M
Citation: C. Maugeais et al., Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia, J CLIN END, 86(4), 2001, pp. 1679-1686
Authors:
Frenais, R
Ouguerram, K
Maugeais, C
Mahot, P
Charbonnel, B
Magot, T
Krempf, M
Citation: R. Frenais et al., Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus, ATHEROSCLER, 157(1), 2001, pp. 131-135
Authors:
Charbonnel, B
Citation: B. Charbonnel, Hormone replacement therapy for menopause with respect to cardiovascular protection: is it safe?, ANN ENDOCR, 62(4), 2001, pp. 252-254
Authors:
Detournay, B
Cros, S
Charbonnel, B
Grimaldi, A
Liard, F
Cogneau, J
Fagnani, F
Eschwege, E
Citation: B. Detournay et al., Managing type 2 diabetes in France: The ecodia survey, DIABETE MET, 26(5), 2000, pp. 363-369
Authors:
Charbonnel, B
Citation: B. Charbonnel, Type 2 diabetes: strategy for patient management excepting complications., DIABETE MET, 26(3), 2000, pp. 232-243
Authors:
Charbonnel, B
Citation: B. Charbonnel, Management of insulin therapy in France. Results from the scheme survey., DIABETE MET, 26, 2000, pp. 21-23
Authors:
Charbonnel, B
Passa, P
Citation: B. Charbonnel et P. Passa, Blood glucose peaks: An update - Diabete-Grenoble 2000 - Bayer Pharma, Satellite Symposium, 23th Marth 2000, DIABETE MET, 26, 2000, pp. 5-5
Authors:
Cariou, B
Charbonnel, B
Heymann, MF
Bridji, B
Citation: B. Cariou et al., Follicular thyroid carcinoma metastatic to the skin, PRESSE MED, 29(28), 2000, pp. 1557-1558
Authors:
Chanson, P
Boerlin, V
Ajzenberg, C
Bachelot, Y
Benito, P
Bringer, J
Caron, P
Charbonnel, B
Cortet, C
Delemer, B
Escobar-Jimenez, F
Foubert, L
Gaztambide, S
Jockenhoevel, F
Kuhn, JM
Leclere, J
Lorcy, Y
Perlemuter, L
Prestele, H
Roger, P
Rohmer, V
Santen, R
Sassolas, G
Scherbaum, WA
Schopohl, J
Torres, E
Varela, C
Villamil, F
Webb, SM
Citation: P. Chanson et al., Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly, CLIN ENDOCR, 53(5), 2000, pp. 577-586
Authors:
Christin-Maitre, S
Olivennes, F
Dubourdieu, S
Chabbert-Buffet, N
Charbonnel, B
Frydman, R
Bouchard, P
Citation: S. Christin-maitre et al., Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation, CLIN ENDOCR, 52(6), 2000, pp. 721-726
Authors:
Chaillous, L
Lefevre, H
Thivolet, C
Boitard, C
Lahlou, N
Atlan-Gepner, C
Bouhanick, B
Mogenet, A
Nicolino, M
Carel, JC
Lecomte, P
Marechaud, R
Bougneres, P
Charbonnel, B
Sai, P
Citation: L. Chaillous et al., Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial, LANCET, 356(9229), 2000, pp. 545-549
Authors:
Vague, P
Charbonnel, B
Citation: P. Vague et B. Charbonnel, Monitoring of patients with non-insulin-dependent diabetes to the exclusion of complications management, DIABETE MET, 25, 1999, pp. 1-64
Authors:
Drouin, P
Blickle, JF
Charbonnel, B
Eschwege, E
Guillausseau, PJ
Plouin, PF
Daninos, JM
Balarac, N
Sauvanet, JP
Citation: P. Drouin et al., Diagnosis and classification of diabetes mellitus: the new criteria., DIABETE MET, 25(1), 1999, pp. 72-83
Authors:
Charbonnel, B
Allouch, H
Citation: B. Charbonnel et H. Allouch, Comments on the new classification of diagnostic criteria for diabetes, PRESSE MED, 28(7), 1999, pp. 354-357
Authors:
Charbonnel, B
Aptel, I
Amouyel, P
Attali, JR
Aulanier, S
Balarac, N
Bukowski, JV
Cathelineau, B
de Broucker, T
Denis, C
Mausset, J
Ormieres, JJ
Passa, P
Paulhan, A
Pousset, F
Pouteil-Noble, C
Laversin, S
Anouchian, P
Aquino, JP
Aubert, JP
Baufine-Ducrocq, H
Bernard, MH
Bonnet, A
Chabassol, E
Cirioni, A
Colas, C
Cordonnier, D
Coscas, G
Cuvelier, D
Dany, F
Derrien, G
Desrousseaux, B
Dueymes, JM
Dupasquier, JP
Dussart, L
Gemez-Lestradet, C
Gerson, M
Grimaldi, A
Gros, M
Guerot, C
Guyot-Argenton, C
Halimi, S
Kourilsky, O
Laneelle, D
Laudet, J
Lelong, S
Malinsky, M
Meffre, C
Moulin, P
Olaya, E
Razongles, P
Said, G
Vague, P
Citation: B. Charbonnel et al., Follow-up of type 2 diabetes patients (excluding complications), PRESSE MED, 28(19), 1999, pp. 1023-1027
Authors:
Allouch, H
Charbonnel, B
Citation: H. Allouch et B. Charbonnel, Follow-up of type 2 diabetes patients - Interview with B. Charbonnel on diabetes, PRESSE MED, 28(19), 1999, pp. 1027-1029
Authors:
Colombel, A
Murat, A
Krempf, M
Kuchly-Anton, B
Charbonnel, B
Citation: A. Colombel et al., Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections, DIABET MED, 16(4), 1999, pp. 319-324
Authors:
Aptel, I
Charbonnel, B
Citation: I. Aptel et B. Charbonnel, Medical recommendations and references about follow-up of class 2 diabeticpatient excluding complications, J MAL VASC, 24(3), 1999, pp. 239-244
Authors:
Chambonet, JY
Bariatinsky-Mahot, N
Dauget, C
Charbonnel, B
Krempf, M
Senand, R
Citation: Jy. Chambonet et al., How do family physicians from the Loire-Atlantique and Morbihan regions ofFrance manage type 2 diabetes mellitus?., SEM HOP PAR, 75(31-32), 1999, pp. 1157-1165